Ocugen Total Other Income Expense Net vs Net Income From Continuing Ops Analysis
| OCGN Stock | USD 1.73 0.14 8.81% |
Ocugen financial indicator trend analysis is much more than just breaking down Ocugen Inc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ocugen Inc is a good investment. Please check the relationship between Ocugen Total Other Income Expense Net and its Net Income From Continuing Ops accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocugen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Total Other Income Expense Net vs Net Income From Continuing Ops
Total Other Income Expense Net vs Net Income From Continuing Ops Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ocugen Inc Total Other Income Expense Net account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have very week relationship.
The correlation between Ocugen's Total Other Income Expense Net and Net Income From Continuing Ops is 0.2. Overlapping area represents the amount of variation of Total Other Income Expense Net that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Ocugen Inc, assuming nothing else is changed. The correlation between historical values of Ocugen's Total Other Income Expense Net and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Other Income Expense Net of Ocugen Inc are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Total Other Income Expense Net i.e., Ocugen's Total Other Income Expense Net and Net Income From Continuing Ops go up and down completely randomly.
Correlation Coefficient | 0.2 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Total Other Income Expense Net
Net Income From Continuing Ops
Most indicators from Ocugen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ocugen Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocugen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. At this time, Ocugen's Selling General Administrative is very stable compared to the past year. As of the 2nd of June 2024, Tax Provision is likely to grow to 0.00, while Issuance Of Capital Stock is likely to drop about 19.8 M.
Ocugen fundamental ratios Correlations
Click cells to compare fundamentals
Ocugen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ocugen fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 16.8M | 27.4M | 105.8M | 108.6M | 64.5M | 48.2M | |
| Other Current Liab | 206.0K | 9.8K | 293K | (1.3M) | 2.8M | 3.0M | |
| Total Current Liabilities | 4.5M | 3.6M | 7M | 18.5M | 17.1M | 17.9M | |
| Total Stockholder Equity | 11.0M | 21.6M | 95.8M | 84.1M | 40.6M | 22.2M | |
| Property Plant And Equipment Net | 222.5K | 633.0K | 1.2M | 6.1M | 17.3M | 18.2M | |
| Net Debt | (6.0M) | (21.5M) | (91.7M) | (71.2M) | (32.5M) | (34.1M) | |
| Retained Earnings | (51.5M) | (73.3M) | (131.7M) | (213.0M) | (286.2M) | (271.9M) | |
| Accounts Payable | 1.9M | 395.0K | 2.3M | 8.1M | 3.2M | 2.8M | |
| Cash | 7.4M | 24.0M | 95.0M | 77.6M | 39.5M | 37.6M | |
| Non Current Assets Total | 1.0M | 1.5M | 3.1M | 10.1M | 21.6M | 22.7M | |
| Non Currrent Assets Other | 667.7K | 714.5K | 1.8M | 3.1M | 3.4M | 3.5M | |
| Cash And Short Term Investments | 7.4M | 24.0M | 95.0M | 90.9M | 39.5M | 38.9M | |
| Common Stock Total Equity | 513K | 527.5K | 1.8M | 2.0M | 2.3M | 2.4M | |
| Common Stock Shares Outstanding | 13.9M | 112.2M | 195.0M | 214.6M | 244.3M | 256.5M | |
| Liabilities And Stockholders Equity | 16.8M | 27.4M | 105.8M | 108.6M | 64.5M | 48.2M | |
| Non Current Liabilities Total | 1.2M | 2.2M | 2.9M | 6.1M | 6.9M | 13.1M | |
| Other Current Assets | 8.3B | 1.8B | 7.7M | 7.6M | 3.5M | 3.3M | |
| Other Stockholder Equity | 62.0M | 93.0M | 225.5M | 294.8M | 324.1M | 190.6M | |
| Total Liab | 5.8M | 5.8M | 9.9M | 24.6M | 24.0M | 18.9M | |
| Property Plant And Equipment Gross | 222.5K | 633.0K | 1.5M | 6.7M | 18.5M | 19.4M | |
| Total Current Assets | 15.8M | 25.9M | 102.6M | 98.5M | 43.0M | 42.0M | |
| Accumulated Other Comprehensive Income | (10.9M) | (10.3M) | 0.0 | 26K | 20K | 21K | |
| Common Stock | 527.5K | 1.8M | 2.0M | 2.2M | 2.6M | 2.7M | |
| Short Long Term Debt Total | 1.4M | 2.5M | 3.3M | 6.4M | 6.9M | 7.3M | |
| Current Deferred Revenue | 2.3M | 2.9M | 4.0M | 11.2M | 10.5M | 5.6M | |
| Other Assets | 474.2K | 432.1K | 2.0M | 177K | 203.6K | 193.4K | |
| Long Term Debt | 1.1M | 1.8M | 1.7M | 2.3M | 2.8M | 1.5M | |
| Capital Surpluse | 215.9M | 62.0M | 93.1M | 225.5M | 203.0M | 137.0M | |
| Short Term Debt | 172.3K | 278.4K | 363K | 498K | 574K | 1.0M | |
| Property Plant Equipment | 222.5K | 1.1M | 1.2M | 10.0M | 11.5M | 12.0M | |
| Net Tangible Assets | 11.0M | 21.6M | 95.8M | 84.1M | 96.7M | 101.5M | |
| Net Invested Capital | 12.1M | 23.6M | 97.5M | 86.3M | 43.4M | 39.5M | |
| Net Working Capital | 11.2M | 22.3M | 95.6M | 80.0M | 25.9M | 39.7M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocugen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Ocugen Inc information on this page should be used as a complementary analysis to other Ocugen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Ocugen Stock analysis
When running Ocugen's price analysis, check to measure Ocugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocugen is operating at the current time. Most of Ocugen's value examination focuses on studying past and present price action to predict the probability of Ocugen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocugen's price. Additionally, you may evaluate how the addition of Ocugen to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
Is Ocugen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocugen. If investors know Ocugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.23) | Revenue Per Share 0.026 | Quarterly Revenue Growth 1.289 | Return On Assets (0.50) | Return On Equity (1.09) |
The market value of Ocugen Inc is measured differently than its book value, which is the value of Ocugen that is recorded on the company's balance sheet. Investors also form their own opinion of Ocugen's value that differs from its market value or its book value, called intrinsic value, which is Ocugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocugen's market value can be influenced by many factors that don't directly affect Ocugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.